Patents by Inventor Brian Eric Schwartz

Brian Eric Schwartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Organoarsenic compounds and methods for the treatment of cancer
    Patent number: 11324713
    Abstract: A method for treating a lymphoma selected from non-Hodgkin's and Hodgkin's lymphoma comprising administering an organoarsenic compound having a structure of the formula (I) wherein X is S or Se and R1 and R2 are independently C1-30alkyl (R3, R3?, R4, R5, W and “n” are as defined in claim 1) in particular where the compound is S-dimethylarsinoglutathione, N-(2-S-dimethylarsinothiopropionyl)glycine, 2-amino-3-(dimethylarsino)thio-3-methylbutanoic acid, S-dimethylarsino-thiosuccinic acid or S-dipropylarsino-1-thioglycerol.
    Type: Grant
    Filed: October 15, 2020
    Date of Patent: May 10, 2022
    Assignee: SOLASIA PHARMA K.K.
    Inventors: Brian Eric Schwartz, Jonathan Lewis, Philip B. Komarnitsky
  • Organoarsenic compounds and methods for the treatment of cancer
    Patent number: 11324714
    Abstract: A method for treating a lymphoma selected from non-Hodgkin's and Hodgkin's lymphoma comprising administering an organoarsenic compound having a structure of the formula (I) wherein X is S or Se and R1 and R2 are independently C1-30alkyl (R3, R3?, R4, R5, W and “n” are as defined in claim 1) in particular where the compound is S-dimethylarsinoglutathione, N-(2-S-dimethylarsinothiopropionyl)glycine, 2-amino-3-(dimethylarsino)thio-3-methylbutanoic acid, S-dimethylarsino-thiosuccinic acid or S-dipropylarsino-1-thioglycerol.
    Type: Grant
    Filed: October 15, 2020
    Date of Patent: May 10, 2022
    Assignee: SOLASIA PHARMA K.K.
    Inventors: Brian Eric Schwartz, Jonathan Lewis, Philip B. Komarnitsky
  • ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20210038557
    Abstract: A method for treating a lymphoma selected from non-Hodgkin's and Hodgkin's lymphoma comprising administering an organoarsenic compound having a structure of the formula (I) wherein X is S or Se and R1 and R2 are independently C1-30alkyl (R3, R3?, R4, R5, W and “n” are as defined in claim 1) in particular where the compound is S-dimethylarsinoglutathione, N-(2-S-dimethylarsinothiopropionyl)glycine, 2-amino-3-(dimethylarsino)thio-3-methylbutanoic acid, S-dimethylarsino-thiosuccinic acid or S-dipropylarsino-1-thioglycerol.
    Type: Application
    Filed: October 15, 2020
    Publication date: February 11, 2021
    Applicant: SOLASIA PHARMA K.K.
    Inventors: Brian Eric Schwartz, Jonathan Lewis, Philip B. Komarnitsky
  • ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20210038556
    Abstract: A method for treating a lymphoma selected from non-Hodgkin's and Hodgkin's lymphoma comprising administering an organoarsenic compound having a structure of the formula (I) wherein X is S or Se and R1 and R2 are independently C1-30alkyl (R3, R3?, R4, R5, W and “n” are as defined in claim 1) in particular where the compound is S-dimethylarsinoglutathione, N-(2-S-dimethylarsinothiopropionyl)glycine, 2-amino-3-(dimethylarsino)thio-3-methylbutanoic acid, S-dimethylarsino-thiosuccinic acid or S-dipropylarsino-1-thioglycerol.
    Type: Application
    Filed: October 15, 2020
    Publication date: February 11, 2021
    Applicant: SOLASIA PHARMA K.K.
    Inventors: Brian Eric Schwartz, Jonathan Lewis, Philip B. Komarnitsky
  • Organoarsenic compounds and methods for the treatment of cancer
    Patent number: 10842769
    Abstract: A method for treating a lymphoma selected from non-Hodgkin's and Hodgkin's lymphoma comprising administering an organoarsenic compound having a structure of the formula (I) wherein X is S or Se and R1 and R2 are independently C1-30alkyl (R3, R3?, R4, R5, W and “n” are as defined in claim 1) in particular where the compound is S-dimethylarsinoglutathione, N-(2-S-dimethylarsinothiopropionyl)glycine, 2-amino-3-(dimethylarsino)thio-3-methylbutanoic acid, S-dimethylarsino-thiosuccinic acid or S-dipropylarsino-1-thioglycerol.
    Type: Grant
    Filed: October 27, 2014
    Date of Patent: November 24, 2020
    Assignee: SOLASIA PHARMA K.K.
    Inventors: Brian Eric Schwartz, Jonathan Lewis, Philip B. Komarnitsky
  • ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20150231107
    Abstract: A method for treating a lymphoma selected from non-Hodgkin's and Hodgkin's lymphoma comprising administering an organoarsenic compound having a structure of the formula (I) wherein X is S or Se and R1 and R2 are independently C1-30alkyl (R3, R3?, R4, R5, W and “n” are as defined in claim 1) in particular where the compound is S-dimethylarsinoglutathione, N-(2-S-dimethylarsinothiopropionyl)glycine, 2-amino-3-(dimethylarsino)thio-3-methylbutanoic acid, S-dimethylarsino-thiosuccinic acid or S-dipropylarsino-1-thioglycerol.
    Type: Application
    Filed: October 27, 2014
    Publication date: August 20, 2015
    Inventors: Brian Eric Schwartz, Jonathan Lewis, Philip B. Komarnitsky
  • INDIBULIN THERAPY
    Publication number: 20140193519
    Abstract: The invention provides combination therapy, wherein one or more other therapeutic agents are administered with indibulin or a pharmaceutically acceptable salt thereof and the combination is synergistic. Another aspect of the invention relates to the treatment of cancer with indibulin as a single agent. Another aspect of the invention relates to dosing regimen for administration of oral dosage forms of indibulin.
    Type: Application
    Filed: August 2, 2013
    Publication date: July 10, 2014
    Applicant: ZIOPHARM ONCOLOGY, INC.
    Inventors: Barbara P. Wallner, Brian Eric Schwartz, Philip B. Komarnitsky, Gerald Bacher, Bernhard Kutscher, Gerhard Raab
  • ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20110269697
    Abstract: A method for treating a lymphoma selected from non-Hodgkin's and Hodgkin's lymphoma comprising administering an organoarsenic compound having a structure of the formula (I) wherein X is S or Se and R1 and R2 are independently C1-30alkyl(R3, R3?, R4, R5, W and “n” are as defined in claim 1) in particular where the compound is S-dimethylarsinoglutathione, N-(2-S-dimethylarsinothiopropionyl)glycine, 2-amino-3-(dimethylarsino)thio-3-methylbutanoic acid, S-dimethylarsino-thiosuccinic acid or S-dipropylarsino-1-thioglycerol.
    Type: Application
    Filed: August 14, 2009
    Publication date: November 3, 2011
    Inventors: Brian Eric Schwartz, Jonathan Lewis, Philip B. Komarnitsky
  • Indibulin therapy
    Publication number: 20080241274
    Abstract: The invention provides combination therapy, wherein one or more other therapeutic agents are administered with indibulin or a pharmaceutically acceptable salt thereof and the combination is synergistic. Another aspect of the invention relates to the treatment of cancer with indibulin as a single agent. Another aspect of the invention relates to dosing regimen for administration of oral dosage forms of indibulin.
    Type: Application
    Filed: November 27, 2007
    Publication date: October 2, 2008
    Applicant: ZIOPHARM Oncology, Inc.
    Inventors: Barbara P. Wallner, Brian Eric Schwartz, Philip B. Komarnitsky, Gerald Bacher, Bernhard Kutscher, Gerhard Raab